0
0
Home » Medical Devices » General Surgery » Reproductive Health Devices

Reversible Contraceptive Devices Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030

Reversible Contraceptive Devices Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2030 is built to visualize quantitative market trends within Reproductive Health Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Reversible Contraceptive Devices market for the year 2020 and beyond. Reversible Contraceptive Devices are forms of modern contraceptives that are the most common mode of birth control worldwide. These devices are inserted or implanted into women of child-bearing age, usually for multiple years.

Reversible Contraceptives that remain in use for many years are considered to be “long-acting” and are the most popular class of reversible contraceptive devices. This is in contrast to devices such as diaphragms that must be inserted and removed before and after intercourse. IUDs are further classified in two types, copper IUDs and Hormonal IUDs. While other forms of modern contraceptives are used (including hormone injections, oral pills, and condoms). Modern contraceptives are widely used in the developed world, while usage rates tend to be lower in developing economies. IUDs are the most common type of reversible contraceptive device. The use of IUDs ranges from about 4%-40% of individuals using modern contraceptives, depending on the country and region.

Each of the covered 39 country’s color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key inclusions of the market model are –

Currently marketed Reversible Contraceptive Devices and evolving competitive landscape –

  • Insightful review of the key industry trends.
  • Annualized total Reversible Contraceptive Devices market revenue by segment and market outlooks from 2015-2030.
  • Granular data on total procedures, units, average selling prices and market values by segment.

Global, regional, and country level market specific insights –

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Reversible Contraceptive Devices market.
  • Competitive dynamics insights and trends provided for Reversible Contraceptive Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: AbbVie Inc, Bayer AG, The Cooper Companies Inc, Merck & Co Inc, Meril Life Sciences Pvt Ltd, Pregna International Ltd, Shanghai Dahua Pharmaceuticals Co Ltd, HLL Lifecare Ltd, Kessel Marketing & Vertriebs GmbH, Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.

Scope of the Reversible Contraceptive Devices (General Surgery) market model

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Currently marketed reversible contraceptive devices and evolving competitive landscape:

  • Insightful review of the key industry trends.
  • Annualized total reversible contraceptive devices market revenue by segment and market outlooks from 2015-2030.
  • Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional, and Country level market specific insights include:

  • Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
  • SWOT analysis for reversible contraceptive devices market.
  • Competitive dynamics insights and trends provided for reversible contraceptive devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

What is the Reversible Contraceptive Devices market size during the historical and forecast period?

Reversible Contraceptive Devices market, by segment

Reversible Contraceptive Devices market, by segment

For more segment insights, download a free report sample

What are the key trends within the Reversible Contraceptive Devices market?

The US dominates the North American market for reversible contraceptive devices. This market is expected to grow through the forecast period, in part, due to increasing awareness about family planning from governments. North America has the largest global market share for each reversible contraceptive segment.

The reversible contraceptive devices market is expected to decline in Europe, mainly due to IUDs becoming less commonly used. Europe has the second largest market for reversible contraceptive devices after North America. The largest markets in within Europe is for intrauterine and hormonal IUDs.

The Asia-Pacific region has the third largest market for reversible contraceptive devices after North America and Europe. This is primarily due to widespread promotion of modern contraceptive use by the government in China, and a large proportion of the female population with IUDs.

The reversible contraceptive devices market in South & Central America small, with Brazil making up the largest share of the market in this region.

The reversible contraceptive devices market in the Middle East & Africa region is relatively small and is expected to remain so throughout the forecast period.

Reversible Contraceptive Devices market report scope

Market value (Year – 2021) $2,398.9 million
Segmentation Diaphragms, Hormonal Implants, and Intrauterine Devices (IUDs)
Key companies AbbVie Inc, Bayer AG, The Cooper Companies Inc, Merck & Co Inc, Meril Life Sciences Pvt Ltd, Pregna International Ltd, Shanghai Dahua Pharmaceuticals Co Ltd, HLL Lifecare Ltd, Kessel Marketing & Vertriebs GmbH
Regions covered North America, South & Central America, Europe, Middle East & Africa, Asia-Pacific
Countries covered US, Canada, Mexico, France, Germany, Italy, Spain, United Kingdom, Austria, Belgium, Czech Republic, Denmark, Finland, Greece, Hungary, Ireland, Netherlands, Norway, Poland, Portugal, Russia, Sweden, Switzerland, Turkey, Australia, China, India, Japan, New Zealand, South Korea, Taiwan, Argentina, Brazil, Chile, Egypt, Israel, Saudi Arabia, South Africa, United Arab Emirates

Who are the Reversible Contraceptive Devices market vendors?

The model analyses the competitive landscape of the reversible contraceptive devices market and includes information on key market vendors:

AbbVie Inc, Bayer AG, The Cooper Companies Inc, Merck & Co Inc, Meril Life Sciences Pvt Ltd, Pregna International Ltd, Shanghai Dahua Pharmaceuticals Co Ltd, HLL Lifecare Ltd, and Kessel Marketing & Vertriebs GmbH.

Scope

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for –

– CMO executives who must have deep understanding of the Reversible Contraceptive Devices marketplace to make strategic planning and investment decisions.

– Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.

– Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to –

– Understand the impact of COVID-19 on Reversible Contraceptive Devices market.

– Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.

– Develop business strategies by understanding the trends shaping and driving Reversible Contraceptive Devices market.

– Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Reversible Contraceptive Devices market in the future.

– Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.

– Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.

– Track device sales in the global and country-specific Reversible Contraceptive Devices market from 2015-2030.

– Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Key Players

AbbVie Inc

Bayer AG

The Cooper Companies Inc

Merck & Co Inc

Meril Life Sciences Pvt Ltd

Pregna International Ltd

Shanghai Dahua Pharmaceuticals Co Ltd

HLL Lifecare Ltd

Kessel Marketing & Vertriebs GmbH

Others

Table of Contents

 

List of Tables

 

List of Figures

 

Frequently Asked Questions

The reversible contraceptive devices market in 2021 is worth $2,398.9 million.

The reversible contraceptive devices market has been segmented by devices (Diaphragms, Hormonal Implants, and Intrauterine Devices (IUDs)) and by 5 regions (North America, South & Central America, Europe, Middle East & Africa and Asia-Pacific) and 39 countries.

Key players in the reversible contraceptive devices market include AbbVie Inc, Bayer AG, The Cooper Companies Inc, Merck & Co Inc, Meril Life Sciences Pvt Ltd, Pregna International Ltd, Shanghai Dahua Pharmaceuticals Co Ltd, HLL Lifecare Ltd, and Kessel Marketing & Vertriebs GmbH

Bayer AG Inc has the largest market share in the reversible contraceptive devices.

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2960

Join our mailing list

Saved reports